This molecule was engineered to harbor a mouse IgG2aσ silent Fc (Fig. 1A), with one variable region arm specific for mouse CD3ɛ and the other arm specific for human EpCAM to permit targeting of murine tumor cells expressing human EpCAM. This evidence concerns the gene EPCAM and neoplasm.